Infectious Diseases News and Research

RSS

International research collaboration to investigate the role of immune system in health

An international research collaboration to pioneer the field of immuno-cardiology and investigate ways to harness the power of the immune system to improve recovery from heart attacks will be led at the Perelman School of Medicine at the University of Pennsylvania by Jonathan Epstein, MD, executive vice dean, chief scientific officer and the William Wikoff Smith Professor of Cardiovascular Research.

13 Jul 2020

Altimmune announces positive preclinical results of intranasal COVID-19 vaccine candidate

Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.

13 Jul 2020

Drug associated with lower mortality in mechanically ventilated COVID-19 patients

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to a new study by a team from the University of Michigan.

13 Jul 2020

Experts create new, evidence-based guideline for treatment of NTM lung disease

NTMs are closely related to tuberculosis bacteria and can (but do not need to) cause infectious diseases in humans. They are called "nontuberculous mycobacteria" (NTMs) to distinguish them from tuberculosis bacteria.

13 Jul 2020

Next showdown in Congress: Protecting workers vs. protecting employers in the pandemic

Congressional leaders are squaring off over the next pandemic relief bill in a debate over whom Congress should step up to protect: front-line workers seeking more safeguards from the ravages of COVID-19 or beleaguered employers seeking relief from lawsuits.

13 Jul 2020

Novel drug could enable the immune system to attack ovarian cancer

A drug known as SP-2577 could help enable the body's own immune system to attack ovarian cancer, according to a study led by the Translational Genomics Research Institute, an affiliate of City of Hope.

13 Jul 2020

Single dose of flu drug can prevent influenza spread among household contacts

A single dose of the flu drug baloxavir marboxil can reduce the spread of the illness within households, new research concludes.

13 Jul 2020

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

EKF Diagnostics the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.

From EKF Diagnostics 13 Jul 2020

New guidance published for research on HIV, co-infections in pregnancy

Pregnant women are among those most in need of safe and effective preventives and treatments for HIV and co-infections. Yet because they are commonly excluded from research, they are among the least likely to have robust, timely evidence to inform decisions around the use of medications.

12 Jul 2020

New mutation in common subtype of influenza virus helps evade immune response

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

12 Jul 2020

Study documents intrauterine transmission of SARS-CoV-2 infection during pregnancy

A baby girl in Texas - born prematurely to a mother with COVID-19 - is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

12 Jul 2020

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Lopinavir is a drug against HIV, hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS-CoV-2.

11 Jul 2020

Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

Black men in the United States are known to suffer disproportionately from prostate cancer, but few studies have investigated whether genetic differences in prostate tumors could have anything to do with these health disparities.

11 Jul 2020

Establishment of global surveillance network can warn about next pandemic

The virus that causes COVID-19 probably originated in wild bats that live in caves around Wuhan, China, and may have been passed to a second animal species before infecting people, according to the World Health Organization.

10 Jul 2020

Scientists recommend a decentralized biosurveillance system to protect from diseases

The emergence of COVID-19 is a powerful reminder of how unchecked wildlife trade can lead to the spillover spread of viruses between wildlife and humans.

10 Jul 2020

Volunteers can now register for coronavirus disease vaccine trials

In an attempt to recruit many volunteers, the National Institute of Allergy and Infectious Diseases (NIAID) has established a new clinical COVID-19 Prevention Trials Network (COVPN) that aims to enroll thousands of volunteers to test various investigational vaccines against the SARS-CoV-2 infection.

10 Jul 2020

Front-line health care workers tested positive for COVID-19 may not have typical symptoms

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.

9 Jul 2020

Challenges in evaluating the efficacy of SARS-CoV-2 vaccines

With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

9 Jul 2020

Remdesivir potently inhibits SARS-CoV-2 in human lung cell cultures

The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.

9 Jul 2020

UHN leads first-of-its-kind real world evidence study of medical cannabis

Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating Canadians about chronic pain management and the risk factors of continued opioid use.

9 Jul 2020

Infectious Diseases News and Research

International research collaboration to investigate the role of immune system in health

Altimmune announces positive preclinical results of intranasal COVID-19 vaccine candidate

Drug associated with lower mortality in mechanically ventilated COVID-19 patients

Experts create new, evidence-based guideline for treatment of NTM lung disease

Next showdown in Congress: Protecting workers vs. protecting employers in the pandemic

Novel drug could enable the immune system to attack ovarian cancer

Single dose of flu drug can prevent influenza spread among household contacts

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

New guidance published for research on HIV, co-infections in pregnancy

New mutation in common subtype of influenza virus helps evade immune response

Study documents intrauterine transmission of SARS-CoV-2 infection during pregnancy

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

Establishment of global surveillance network can warn about next pandemic

Scientists recommend a decentralized biosurveillance system to protect from diseases

Volunteers can now register for coronavirus disease vaccine trials

Front-line health care workers tested positive for COVID-19 may not have typical symptoms

Challenges in evaluating the efficacy of SARS-CoV-2 vaccines

Remdesivir potently inhibits SARS-CoV-2 in human lung cell cultures

UHN leads first-of-its-kind real world evidence study of medical cannabis

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News